XClose

Euro Ewing Consortium

International Clinical Trials to Improve Survival from Ewing Sarcoma
Menu

rEECur results - September 2018

The rEECur trial has been recruiting patients since January 2015 and while the trial data will not be analysed until the study has closed, progress with the trial up to September 2018 is summarised below. 

rEECur - recruitment by country

Country Number of patients
United Kingdom
84
Spain
63
France
53
Italy
30
Hungary
8
Denmark
8
Norway
3
Netherlands
2
Czech Republic
2
Belgium
2
Poland
1
Switzerland
1
Finland
1
Australia
0

rEECur - gender of patients

Gender Number of patients
Male
175
Female
83

rEECur - age of patients

Age Number of patients
Number of patients under 14 years
50
Number of patients ≥14 years ≤ 25 years
120
Number of patients over 25 years
88